Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Red~Oneon Nov 07, 2021 6:20pm
484 Views
Post# 34097946

Penny Stocks

Penny StocksCopied from another site:

Confession of a Pumper:

“It wasn't supposed to happen like this, it started out with a small trade of 10k shares just to get a taste, a position, in a Pharma stock in a hot sector. Then I got caught up in the news, it sounded like this was going to be big. I bought more. Then things dragged on and it started to go south, so I bought more on the dip. Didn't tell my partner, not their business, besides I'm just trying to do the right thing. Got some extra money so I bought more, I love this stock. Can't believe some people don't like this stock, this product will be a game changer one day, it will save the world, front page news.
Then the company contacted me to see if I would help promote this beautiful product, I could get bonuses for my efforts, be a part of a team. "Of course" I said yes, "when do we start?" Things got better immediately, and I got paid in shares, perfect. Then things continued to go down, bad news releases, delays, long timelines but what an amazing idea for a product, am I the only one that can see that, we just need more money to develop it. Can you help more they said, we have a script. I need to pay my bills I said, timeline sucks, got more shares as a bonus but may have to sell them low, so yeah I'll do what I can. "No problem we will have a unique product that "big pharma" will be begging for in a year or so" they said.
I love this stock.”


<< Previous
Bullboard Posts
Next >>